Neurocrine

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.

About NBIX

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids.

CEO

Kyle W. Gano

CEOKyle W. Gano

Employees

1,800

Employees1,800

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1992

Founded1992

Employees

1,800

Employees1,800

NBIX Key Statistics

Market cap

14.16B

Market cap14.16B

Price-Earnings ratio

41.59

Price-Earnings ratio41.59

Dividend yield

—

Dividend yield—

Average volume

749.76K

Average volume749.76K

High today

$143.39

High today$143.39

Low today

$141.20

Low today$141.20

Open price

$141.67

Open price$141.67

Volume

611.45K

Volume611.45K

52 Week high

$154.61

52 Week high$154.61

52 Week low

$84.23

52 Week low$84.23

Analyst ratings

86%

of 29 ratings

Buy

86.2%

Hold

13.8%

Sell

People also own

Based on the portfolios of people who own NBIX. This list is generated using Robinhood data, and it’s not a recommendation.

Take-Two Interactive Soft…

Salesforce